Investors
The merging of drug and medical device sectors is now a huge business. According to BCC, market analysts, the Coatings and Surface Treatment processes in the Medical Device Market is forecasted to grow from $2.96 to $5.31 billon by 2010. These strong growth rates combined with other market drivers like demographic trends (ageing population profile) and increasing consumer emphasis on healthcare results is a very attractive market for EnBIO’s products. EnBIO’s surface modification technologies are classified as ‘active coatings’, a subcategory within the above market. The market for this type of coating is forecasted to grow even faster at an annual rate of 65.9% for the next four years.
The dramatic changes brought about by drug elution capabilities on combination medical devices have created a new, distinct but highly fragmented market. The requirements for innovative development capability coupled with the need to enhance existing mature medical device products with leading edge technology (increase margins) has now created a new, distinct marketplace with limited competition; no single company has more than 10% market share.
EnBIO’s technology positions the Company in a potentially market leading position given its unique patented surface modification technology. Its technology platform is a new and novel process for applying currently used agents to metal implants resulting in dramatically reduced application costs, significantly enhanced surface finish characteristics and superior end product quality. Additionally, this new process technology has the capability of applying a wide and growing range of medical agents onto the metal surface of medical implant.
site design: